Results 161 to 170 of about 622,221 (202)
Some of the next articles are maybe not open access.
Reviews in Medical Virology, 2000
Human herpesvirus 6 (HHV-6), a member of the beta-herpesvirinae subfamily, is highly seroprevalent, has a worldwide distribution, and infection usually occurs within the first two years of life. In this age group, HHV-6 causes febrile illness including exanthem subitum with seizures a recognised complication.
openaire +2 more sources
Human herpesvirus 6 (HHV-6), a member of the beta-herpesvirinae subfamily, is highly seroprevalent, has a worldwide distribution, and infection usually occurs within the first two years of life. In this age group, HHV-6 causes febrile illness including exanthem subitum with seizures a recognised complication.
openaire +2 more sources
Human Herpesvirus 6 and Pneumonia
Leukemia & Lymphoma, 1994Studies of lung tissues and bronchoalveolar lavage specimens from patients with pneumonia have led some investigators to propose that human herpesvirus 6 (HHV-6) can cause pneumonia. As the etiologic role of HHV-6 in pneumonia remains poorly defined, cases of pneumonia that are associated with pulmonary HHV-6 infection are best described as HHV-6 ...
R W, Cone, M L, Huang, R C, Hackman
openaire +2 more sources
The Lancet, 1994
Multiple lines of clinical and experimental evidence suggest that human herpesvirus 6 (HHV-6) may act as an accelerating factor in the natural history of human immunodeficiency virus (HIV) infection. Although, in common with HIV, HHV-6 has a primary tropism for CD4+ T cells, its potential effects on the immune system are broader.
P, Lusso, R C, Gallo
openaire +3 more sources
Multiple lines of clinical and experimental evidence suggest that human herpesvirus 6 (HHV-6) may act as an accelerating factor in the natural history of human immunodeficiency virus (HIV) infection. Although, in common with HIV, HHV-6 has a primary tropism for CD4+ T cells, its potential effects on the immune system are broader.
P, Lusso, R C, Gallo
openaire +3 more sources
Human Herpesvirus Type 6: Review
Clinical Infectious Diseases, 1992Human herpesvirus type 6 (HHV-6), a newly recognized human herpesvirus first described in 1986, is morphologically similar to other herpesviruses but is distinguishable from all of them by some unique in vitro biological effects, specific antigenic analysis, and patterns of endonuclease restriction digests of DNA. In vitro HHV-6 exhibits tropism mainly
I, Oren, J D, Sobel
openaire +2 more sources
Human herpesvirus 6 (HHV6) infection
The Indian Journal of Pediatrics, 2004Human herpes virus-6 was first reported in 1986 and is the sixth member of the herpes virus family. HHV-6 consists of two closely related variants HHV-6A and HHV-6B. The majority of infections occur in healthy infants with most infections caused by HHV-6B.
Nahed M, Abdel-Haq, Basim I, Asmar
openaire +2 more sources
Human Herpesvirus-6 and Human Herpesvirus-7
1997Human herpesvirus type 6 (HHV-6) and human herpes-virus type 7 (HHV-7) are two of the most recently characterized viruses in the group that includes herpes simplex virus 1 (HHV-1), herpes simplex virus 2 (HHV-2), varicellazoster (HHV-3), Epstein—Barr virus (EBV) (HHV-4), cytomegalovirus (CMV) (HHV-5), and the Kaposi’s sarcoma-associated herpesvirus HHV-
openaire +1 more source
Bailliere's clinical haematology, 1995
HHV-6, the first T-lymphotropic human herpesvirus, is an important novel human pathogen. It is the cause of exanthem subitum in infants and may act as an opportunistic agent in immunocompromised patients. Moreover, several lines of clinical and experimental evidence suggest that HHV-6 may accelerate the progression of HIV infection.
P, Lusso, R C, Gallo
openaire +1 more source
HHV-6, the first T-lymphotropic human herpesvirus, is an important novel human pathogen. It is the cause of exanthem subitum in infants and may act as an opportunistic agent in immunocompromised patients. Moreover, several lines of clinical and experimental evidence suggest that HHV-6 may accelerate the progression of HIV infection.
P, Lusso, R C, Gallo
openaire +1 more source
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly